This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
The outcomes estimated from the literature were: the prevalence of disease, the proportion of AAA qualified and fit for immediate surgery, the attendance rate, the proportion of opportunistically detected AAA, the AAAs yearly risk for non-ruptured AAA surgery, mortality for non-rupture AAA surgery, total mortality for ruptured AAA, the yearly risk of rupture among those with AAA, and relative long-term mortality for an AAA patient.
Study designs and other criteria for inclusion in the review
A systematic review of the literature was undertaken to identify relevant studies for populating the decision model. Much of the data were retrieved from the published decision model when important differences between men and women were found in the literature. The inclusion criteria for primary studies were as follows: only open repair was assessed in the model, and a distinction between surgery for ruptured and non-ruptured AAA should be possible.
The authors reported only limited information on the design of the primary studies. Four screening studies were used to obtain the ratio between men and women for AAA prevalence, while Swedish statistics were used for age-and genderspecific mortality rates.
Sources searched to identify primary studies
MEDLINE was searched through January 2005, combining the keywords "abdominal aortic aneurysm" with the terms "gender", "sex", "women" and "female".
Criteria used to ensure the validity of primary studies
Not reported.
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
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Twenty primary studies provided clinical data.
Methods of combining primary studies
Investigation of differences between primary studies
Not reported
Results of the review
Data were reported for both women and men (the latter data are in brackets), because some data for women were adapted from data for men obtained from the previous model.
The rate of prevalence was 1.10% (5.50%).
The proportion of AAA qualified and fit for immediate surgery was 6.80% (6.80%).
The attendance rate was 72% (80%).
The proportion of opportunistically detected AAA was 13% (13%).
The yearly risk for non-ruptured AAA surgery in the screened group was 3.12% (3.90%).
The AAAs yearly risk for non-ruptured AAA surgery in the non-screened group was 1.12% (1.40%).
The mortality rate for non-ruptured AAA surgery was 3.50% (3.10%).
The total mortality for ruptured AAA was 86.30% (79%).
The yearly risk of rupture among those with AAA in the screened group was 2.40% (0.80%).
The yearly risk of rupture among those with AAA in the non-screened group was 5.70% (1.90%).
The relative long-term mortality for an AAA patient was 3.59 (2.05).
Measure of benefits used in the economic analysis
The summary benefit measure used was the expected number of life-years saved with screening in comparison with no screening. This was obtained from the decision model. Rupture incidence and AA-related mortality rates were also reported. An annual discount rate of 3% was applied.
Direct costs
The perspective of the study was not explicitly stated, but both direct medical and non-medical costs were considered. The analysis considered the costs associated with screening (invitation, ultrasound and travelling to screening), followup (yearly control visits for patients with a detected AAA), elective AAA surgery and surgery for a ruptured AAA. The unit costs were reported separately from the quantities of resources used for most items. Resource use appears to have been based on authors' opinions. The costs came from a study published in 2002 and from hospital price lists. Discounting was relevant, as the long-term costs were estimated, and an annual rate of 3% was used. The costs were updated to 2004 values (the price year) using the Swedish Consumer Price Index.
